Hemostatic System Articles & Analysis
5 news found
EndoClot® SIA is the first starch-derived submucosal injection system cleared in the U.S. market for endoscopic removal of polyps, adenomas, early stage cancers and other gastrointestinal mucosal lesions. ...
Endomedix, Inc., a developer of unique biosurgical products based on natural biopolymer systems, today announced it will provide the first public presentation of its work at a scientific meeting. ...
Endomedix, Inc., a developer of unique biosurgical products based on its natural biopolymer systems, today announced that it has submitted a comprehensive patent application to protect both its latest chemistry technology and also the design and function of the spray-on hydrogel hemostat that it is developing for brain and spine surgery indications. ...
EndoClot® Adhesive is a single-use kit that consists of Adhesive Hemostatic Polymer (AHP) and a unique applicator system to ensure accurate delivery of the hemostatic powder to the lesion within the GI tract. ...
Endomedix, Inc. announced today that NIH has selected Endomedix to showcase its technology at the upcoming Biotechnology Industry Organization (BIO) annual meeting in Philadelphia, June 15-18, 2015. The National Institute for Neurological Disorders and Stroke is currently funding the Endomedix program to develop a surgical hemostat indicated for use in intracranial surgery through a multi-year ...